
Pluri Inc. – NASDAQ:PLUR
Pluri stock price today
Pluri stock price monthly change
Pluri stock price quarterly change
Pluri stock price yearly change
Pluri key metrics
Market Cap | 25.07M |
Enterprise value | 27.56M |
P/E | -0.92 |
EV/Sales | 85.35 |
EV/EBITDA | -0.86 |
Price/Sales | 91.46 |
Price/Book | 1.27 |
PEG ratio | N/A |
EPS | -6.08 |
Revenue | N/A |
EBITDA | -27.97M |
Income | -28.58M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -10292.57% |
Oper. margin | -8136.22% |
Gross margin | 0% |
EBIT margin | -8136.22% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePluri stock price history
Pluri stock forecast
Pluri financial statements
Jun 2022 | 0 | -9.20M | |
---|---|---|---|
Mar 2023 | 87K | -7.62M | -8763.22% |
Jun 2023 | 111K | -6.45M | -5818.92% |
Mar 2024 | 71K | -5.29M | -7454.93% |
2026 | 12.55M | -22.35M | -178.06% |
---|
Analysts Price target
Financials & Ratios estimates
2022-11-10 | -0.1128 | -0.19 |
---|---|---|
2023-02-13 | -0.24 | -0.24 |
Dec 2022 | 59927000 | 34.96M | 58.34% |
---|---|---|---|
Mar 2023 | 56241000 | 35.36M | 62.87% |
Jun 2023 | 50797000 | 35.49M | 69.88% |
Mar 2024 | 36390000 | 34.54M | 94.93% |
Jun 2022 | -8.42M | -2.95M | -1.24M |
---|---|---|---|
Mar 2023 | -6.07M | -1.68M | 2.34M |
Jun 2023 | -2.89M | 4.32M | -10K |
Mar 2024 | -4.20M | 5.66M | 0 |
Pluri alternative data
Aug 2023 | 154 |
---|---|
Sep 2023 | 154 |
Oct 2023 | 154 |
Nov 2023 | 154 |
Dec 2023 | 123 |
Jan 2024 | 123 |
Feb 2024 | 123 |
Mar 2024 | 123 |
Apr 2024 | 123 |
May 2024 | 123 |
Jun 2024 | 123 |
Jul 2024 | 123 |
Pluri other data
Period | Buy | Sel |
---|---|---|
Feb 2022 | 80616 | 0 |
Dec 2022 | 0 | 2000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | ABERMAN ZAMI director | Common Stock | 2,000 | $0.97 | $1,940 | ||
Purchase | ABERMAN ZAMI director | Common Stock | 80,616 | $1.8 | $145,109 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common stock | 45,000 | $3.72 | $167,400 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common stock | 70,007 | $3.72 | $260,426 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common stock | 24,110 | $3.69 | $88,966 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common stock | 71,775 | $3.69 | $264,850 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common Stock | 22,015 | $3.69 | $81,235 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common Stock | 122,663 | $3.68 | $451,400 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common stock | 261,238 | $3.84 | $1,003,154 | ||
Sale | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 10 percent owner | Common Stock | 79,300 | $3.83 | $303,719 |
-
What's the price of Pluri stock today?
One share of Pluri stock can currently be purchased for approximately $4.83.
-
When is Pluri's next earnings date?
Unfortunately, Pluri's (PLUR) next earnings date is currently unknown.
-
Does Pluri pay dividends?
No, Pluri does not pay dividends.
-
How much money does Pluri make?
Pluri has a market capitalization of 25.07M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.59% to 326K US dollars. Pluri made a loss 20.89M US dollars in net income (profit) last year or -$0.24 on an earnings per share basis.
-
What is Pluri's stock symbol?
Pluri Inc. is traded on the NASDAQ under the ticker symbol "PLUR".
-
What is Pluri's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Pluri?
Shares of Pluri can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Pluri have?
As Jul 2024, Pluri employs 123 workers.
-
When Pluri went public?
Pluri Inc. is publicly traded company for more then 22 years since IPO on 30 Jun 2003.
-
What is Pluri's official website?
The official website for Pluri is pluri-biotech.com.
-
How can i contact Pluri?
Pluri can be reached via phone at +972 74 710 8600.
Pluri company profile:

Pluri Inc.
pluri-biotech.comNASDAQ
106
Biotechnology
Healthcare
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Haifa, 3508409
CIK: 0001158780
ISIN: US72942G1040
CUSIP: 72942G104